BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28583689)

  • 1. Granulomatous-Lymphocytic Interstitial Lung Disease in a Patient With Common Variable Immunodeficiency.
    Shah JL; Amin SB; Verma N; Mohammed TL
    Curr Probl Diagn Radiol; 2018; 47(4):282-284. PubMed ID: 28583689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
    Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
    Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
    Tashtoush B; Memarpour R; Ramirez J; Bejarano P; Mehta J
    Clin Respir J; 2018 Jan; 12(1):337-343. PubMed ID: 27243233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
    Hasegawa M; Sakai F; Okabayashi A; Sato A; Yokohori N; Katsura H; Asano C; Kamata T; Koh E; Sekine Y; Hiroshima K; Ogura T; Takemura T
    Intern Med; 2017 Nov; 56(21):2899-2902. PubMed ID: 28924106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
    Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
    BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variable immunodeficiency-associated granulomatous and interstitial lung disease.
    Prasse A; Kayser G; Warnatz K
    Curr Opin Pulm Med; 2013 Sep; 19(5):503-9. PubMed ID: 23880700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings.
    Torigian DA; LaRosa DF; Levinson AI; Litzky LA; Miller WT
    J Thorac Imaging; 2008 Aug; 23(3):162-9. PubMed ID: 18728542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency.
    Nishimura M; Miyata J; Tanigaki T; Nomura S; Serizawa Y; Igarashi S; Itou K; Ohno T; Kurata Y; Kimizuka Y; Fujikura Y; Sekinaka Y; Sekinaka K; Matsukuma S; Nonoyama S; Kawana A
    Intern Med; 2023 Mar; 62(6):871-875. PubMed ID: 35945007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common and Uncommon CT Findings in CVID-Related GL-ILD: Correlations with Clinical Parameters, Therapeutic Decisions and Potential Implications in the Differential Diagnosis.
    Scarpa R; Cinetto F; Milito C; Gianese S; Soccodato V; Buso H; Garzi G; Carrabba M; Messina E; Panebianco V; Catalano C; Morana G; Lougaris V; Landini N; Bondioni MP
    J Clin Immunol; 2023 Nov; 43(8):1903-1915. PubMed ID: 37548814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
    Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
    Front Immunol; 2020; 11():617985. PubMed ID: 33584710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined variable immunodeficiency with unusal features. A case report].
    De Charry F; Peterschmitt Tonetti A; De Charry C; Baseggio L; Pasquet F; Khenifer S; Rassat R; Pavic M
    Rev Med Interne; 2015 May; 36(5):359-62. PubMed ID: 24630587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.
    Hurst JR; Verma N; Lowe D; Baxendale HE; Jolles S; Kelleher P; Longhurst HJ; Patel SY; Renzoni EA; Sander CR; Avery GR; Babar JL; Buckland MS; Burns S; Egner W; Gompels MM; Gordins P; Haddock JA; Hart SP; Hayman GR; Herriot R; Hoyles RK; Huissoon AP; Jacob J; Nicholson AG; Rassl DM; Sargur RB; Savic S; Seneviratne SL; Sheaff M; Vaitla PM; Walters GI; Whitehouse JL; Wright PA; Condliffe AM
    J Allergy Clin Immunol Pract; 2017; 5(4):938-945. PubMed ID: 28351785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency.
    Park JE; Beal I; Dilworth JP; Tormey V; Haddock J
    Eur J Radiol; 2005 Jun; 54(3):359-64. PubMed ID: 15899336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse granulomatous disease: looking inside and outside the lungs.
    Williams A; Kelleher WP; Nicholson AG; Devaraj A; Pavesio C; Chua F
    Thorax; 2020 Feb; 75(2):189-191. PubMed ID: 31907202
    [No Abstract]   [Full Text] [Related]  

  • 15. [Granulomatous lymphocytic interstitial lung disease (GLILD) as a manifestation of pulmonary changes in common variable immunodeficiency (CVID) – case report].
    Marciszewska E; Szaflarska A; Pituch-Noworolska A
    Przegl Lek; 2016; 73(7):530-3. PubMed ID: 29677427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
    Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
    Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
    Park JH; Levinson AI
    Clin Immunol; 2010 Feb; 134(2):97-103. PubMed ID: 19900842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.
    Moctezuma SI; Panizo CM; Landecho MF
    Med Clin (Barc); 2017 Oct; 149(7):312-313. PubMed ID: 28736065
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
    Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
    J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report.
    Vitale J; Convers KD; Goretzke S; Guzman M; Noyes B; Parkar N; Knutsen AP
    J Allergy Clin Immunol Pract; 2015; 3(2):273-6. PubMed ID: 25609323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.